Decellularized human amniotic member hydrogel promotes limbal stem cells proliferation
Colloids and Surfaces B: Biointerfaces · 2025
DOI: 10.1016/j.colsurfb.2025.114656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2025. Verfasst von Yongyao Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University ofScience and Technology, Wuhan 430074, China; Hubei Key La…. Hauptthemen laut MEDLINE: Amnion, Stem Cells, Hydrogels, Limbus Corneae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Science and Technology of Hubei Province, Hubei Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Allogeneic cultured limbal epithelial stem cell transplantation has shown variable clinical success in treating limbal stem cell deficiency, low success cases are likely due to insufficient stem cell quantity or functional impairment. In this study, we engineered a decellularized amniotic membrane hydrogel (dAM-gel) using a freeze-thaw protocol designed to retain extracellular matrix integrity. Post-processing, collagen content decreased modestly from 313.50 ± 27.89 μg/mg to 284.8 ± 14.82 μg/mg (P = 0.08), while glycosaminoglycan levels shifted from 7.20 ± 1.66 μg/mg to 6.28 ± 0.55 μg/mg (P = 0.27). Crucially, the protocol achieved near-complete DNA removal (7.41 ± 0.78 μg/mg vs. 0.14 ± 0.06 μg/mg) (P < 0.0001), ensuring minimal immunogenicity. Although the dAM-gel demonstrates limited gelation capacity at lower concentrations, it achieves robust gelation at 14 mg/ml, completing the process within 28.26 ± 1.21 minutes. Furthermore, dAM-gel facilitates the migration and proliferation of limbal stem cells, particularly p63 + cells, which are known to correlate with the success of clinical treatments. A plausible explanation for this phenomenon is that dAM-gel contains a high concentration of agrin, which facilitates the proliferation of limbal stem cells while preserving their stemness via the Yap1-cyclin D1 signaling pathway. In conclusion, dAM-gel derived from amniotic membrane presents therapeutic promise for treating limbal stem cell deficiency by enhancing the proliferation of limbal stem cells while maintaining their stem cell phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University ofScience and Technology, Wuhan 430074, China; Hubei Key Laboratory of Otorhinolaryngologic and Ophthalmic Diseases, Wuhan 430074…
- Department of Ophthalmology and Vision Science, University of Arizona, Tucson, AZ 85710, USA; NeuVision Medical Institute, Tucson, AZ 85718, USA. Electronic address: mwang@eyes.arizona.edu.
Förderung
- Department of Science and Technology of Hubei Province
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Tan, Y., Wang, W., Xu, L., Zhou, X., Shen, J., Zhou, T., Duan, C., Wang, X., Liu, Z., Wang, M., & Li, G. (2025). Decellularized human amniotic member hydrogel promotes limbal stem cells proliferation. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.114656
Vancouver
Tan Y, Wang W, Xu L, Zhou X, Shen J, Zhou T, et al. Decellularized human amniotic member hydrogel promotes limbal stem cells proliferation. Colloids and Surfaces B: Biointerfaces. 2025. doi:10.1016/j.colsurfb.2025.114656
BibTeX
@article{Tan2025,
author = {Tan, Yongyao and Wang, Wei and Xu, Lingjuan and Zhou, Xiao and Shen, Jiachao and Zhou, Tianyu and Duan, Chengen and Wang, Xuying and Liu, Zibin and Wang, Mingwu and Li, Guigang},
title = {Decellularized human amniotic member hydrogel promotes limbal stem cells proliferation},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2025},
doi = {10.1016/j.colsurfb.2025.114656}
}
EUVIMED